Hos patienter med moderat til svær nyreinsufficiens (kreatininclearance < 50 ml/ minut) er clearance reduceret med cirka 50% og steady- state plasmaværdier omtrent fordoblet.
In patients with moderate to severe renal insufficiency (creatinine clearance < 50 ml/ min), the clearance of eptifibatide is reduced by approximately 50% and steady-state plasma levels are approximately doubled.